A Multiple Biomarker Approach in Patients with Cardiac Sarcoidosis
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Sarcoidosis is a systemic granulomatous disease including heart (cardiac sarcoidosis, CS). It has recently been reported that isolated CS, which presenting primarily cardiac symptoms without clinical evidence of sarcoid involvement in other organs. Diagnostic and prognostic biomarkers of CS, especially in isolated CS, have not yet been established.We studied plasma levels of angiotensin-converting enzyme (ACE), soluble interleukin-2 receptor (sIL-2R), B-type natriuretic peptide (BNP) and cardiac troponin I (cTnI) in consecutive 172 patients with diagnosed sarcoidosis. We compared these markers between non-cardiac sarcoidosis (non-CS, n = 123, 71.5%) and CS patients (n = 49, 28.5%), including non-isolated CS (n = 30, 17.4%) and isolated CS (n = 19, 11.1%). ROC analysis revealed that BNP identified CS with AUC of 0.85 (P < 0.01) in sarcoidosis patients. In addition, ACE and sIL-2R levels were significantly higher in non-isolated CS than in isolated CS (P < 0.05). Furthermore, in the Cox proportional hazard analysis, cTnI, but not ACE, IL2R or BNP, was a predictor of fatal arrhythmia in sarcoidosis patients (HR 2.418, P = 0.003).Higher ACE and sIL2-R are associated with systemic lesions, whereas BNP is a useful marker for detecting cardiac involvement in sarcoidosis patients. cTnI is a predictor of fatal arrhythmia in CS patients. A multiple biomarker approach supports comprehensive management of sarcoidosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Elm, E. V., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007) · BMJ · doi:10.1136/bmj.39335.541782.ad · Cited by 10,766
Cited by
Ribeiro Neto, M. L., Jellis, C. L., Joyce, E., Callahan, T. D., Hachamovitch, R., & Culver, D. A. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201902-119cme · Cited by 63
Epidemiology, Pathogenesis, and Diagnosis of Cardiac Sarcoidosis
Mathai, S. V., Patel, S., Jorde, U. P., & Rochlani, Y. (2022) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1057 · Cited by 38
Tan, J. L., Tan, B. E.-X., Cheung, J. W., Ortman, M., & Lee, J. Z. (2023) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2022.04.007 · Cited by 34
Metadata
- Authors
- Kiko, T., Yoshihisa, A., Kanno, Y., Yokokawa, T., Abe, S., Miyata-Tatsumi, M., Misaka, T., Oikawa, M., Kobayashi, A., Ishida, T., & Takeishi, Y.
- Venue
- International Heart Journal
- Published
- 2018-09-01
- Volume
- 59
- Issue
- 5
- Pages
- 996-1001
- ISSN
- 1349-2365 (ISSN-L)
- 1349-3299
- OpenAlex
- W2885556948
- Cited by
- 72
- References
- 3
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Multiple Biomarker Approach in Patients with Cardiac Sarcoidosis. https://app.cochat.ai/papers/10.1536/ihj.17-695
- The paper
- Kiko, T., Yoshihisa, A., Kanno, Y., Yokokawa, T., Abe, S., Miyata-Tatsumi, M., Misaka, T., Oikawa, M., Kobayashi, A., Ishida, T., & Takeishi, Y. (2018). A Multiple Biomarker Approach in Patients with Cardiac Sarcoidosis. International Heart Journal. https://doi.org/10.1536/ihj.17-695
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.